Nucleus RadioPharma
Signal active
Organization
Contact Information
Overview
Nucleus RadioPharma is a new company that was founded to ensure that cancer patients have access to potentially life-saving radiopharmaceuticals by developing technologies to modernise the clinical development, manufacturing, and supply chain of these promising new therapies.
About
Industries
Health Care
Founded
2022
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Nucleus RadioPharma headquartered in United States, North America, operates in the Health Care sector. The company focuses on Health Care and has secured $744.0M in funding across 12 round(s). With a team of 1-10 employees, Nucleus RadioPharma is actively contributing to advancements in Health Care. Their latest funding round, Series A - Nucleus RadioPharma, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
1
Lead Investors
0
Total Funding Amount
$62.0M
Details
3
Nucleus RadioPharma has raised a total of $62.0M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Seed | 6.0M | ||
| 2023 | Early Stage Venture | 56.0M | ||
| 2024 | Early Stage Venture |
Investors
Nucleus RadioPharma is funded by 20 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Granger Management LLC | - | FUNDING ROUND - Granger Management LLC | 56.0M |
| Tyrell Rivers | - | FUNDING ROUND - Tyrell Rivers | undefined |
| Nucleus RadioPharma | - | FUNDING ROUND - Nucleus RadioPharma | undefined |
| AstraZeneca | - | FUNDING ROUND - AstraZeneca | undefined |
Recent Activity
There is no recent news or activity for this profile.